EP3088421
Einstofna mótefni til notkunar við sjúkdómsgreiningu og læknismeðhöndlun á krabbameini og sjálfsónæmissjúkdómi
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
3.7.2013EP published:
27.2.2019EP application number:
16152641.3
EP translation filed:
13.3.2019Grant published:
15.4.2019EPO information:
European Patent Register
Max expiry date:
2.7.2033Expiry date:
2.7.2023
Title:
MONOCLONAL ANTIBODIES FOR USE IN DIAGNOSIS AND THERAPY OF CANCERS AND AUTOIMMUNE DISEASE
Timeline
Today
3.7.2013EP application
27.2.2019EP Publication
13.3.2019Translation submitted
15.4.2019Registration published
2.7.2023Expires
Owner
Name:
Board of Regents, The University of Texas SystemAddress:
210 West 7th Street, 78701, Austin, TX, US
Inventor
Name:
Molldrem, JeffreyAddress:
Houston, TX, US
Name:
Sergeeva, AnnaAddress:
Houston, TX, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261669967 PDate:
10.7.2012Country:
US
Number:
201261702916 PDate:
19.9.2012Country:
US
Classification
Categories:
C07K 16/30, C07K 16/28, A61K 39/395, A61K 39/00, A61P 35/00, A61P 37/00, A61K 45/06, C07K 16/40, G01N 33/574
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 5.6.2019
Expires: 2.7.2020
Payer: Árnason Faktor
Number: 8
Paid: 25.6.2020
Expires: 2.7.2021
Payer: Árnason Faktor ehf.
Number: 9
Paid: 12.7.2021
Expires: 2.7.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 29.6.2022
Expires: 2.7.2023
Payer: Árnason Faktor ehf.